Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity (original) (raw)
Kaisho, T. & Akira, S. Regulation of dendritic cell function through Toll-like receptors. Curr. Mol. Med.3, 373–385 (2003). ArticleCAS Google Scholar
Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol.18, 767–811 (2000). ArticleCAS Google Scholar
Shortman, K. & Liu, Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol.2, 151–161 (2002). ArticleCAS Google Scholar
Cooper, M.A., Fehniger, T.A. & Caligiuri, M.A. The biology of human natural killer-cell subsets. Trends Immunol.22, 633–640 (2001). ArticleCAS Google Scholar
Biron, C.A. & Brossay, L. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol.13, 458–464 (2001). ArticleCAS Google Scholar
Cerwenka, A. & Lanier, L.L. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev.181, 158–169 (2001). ArticleCAS Google Scholar
Wu, J. et al. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J. Immunol.170, 4196–4200 (2003). ArticleCAS Google Scholar
Smith, H.R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA99, 8826–8831 (2002). ArticleCAS Google Scholar
Trinchieri, G., Santoli, D., Dee, R.R. & Knowles, B.B. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J. Exp. Med.147, 1299–1313 (1978). ArticleCAS Google Scholar
Fernandez, N.C. et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med.5, 405–411 (1999). ArticleCAS Google Scholar
Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol.2, 1144–1150 (2001). ArticleCAS Google Scholar
Orange, J.S. & Biron, C.A. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol.156, 4746–4756 (1996). CAS Google Scholar
Granucci, F. et al. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med.200, 287–295 (2004). ArticleCAS Google Scholar
Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med.195, 327–333 (2002). ArticleCAS Google Scholar
Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med.195, 335–341 (2002). ArticleCAS Google Scholar
Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med.195, 343–351 (2002). ArticleCAS Google Scholar
Scalzo, A.A. Successful control of viruses by NK cells–-a balance of opposing forces? Trends Microbiol.10, 470–474 (2002). ArticleCAS Google Scholar
Andrews, D.M., Andoniou, C.E., Granucci, F., Ricciardi-Castagnoli, P. & Degli-Esposti, M.A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol.2, 1077–1084 (2001). ArticleCAS Google Scholar
Dalod, M. et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon-αβ. J. Exp. Med.197, 885–898 (2003). ArticleCAS Google Scholar
Dalod, M. et al. Interferon-αβ and interleukin 12 responses to viral infections: Pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med.195, 517–528 (2002). ArticleCAS Google Scholar
Krug, A. et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity21, 107–119 (2004). ArticleCAS Google Scholar
Dranoff, G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA90, 3539–3543 (1993). ArticleCAS Google Scholar
Gilliet, M. et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by Flt3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med.195, 953–958 (2002). ArticleCAS Google Scholar
Asselin-Paturel, C., Brizard, G., Pin, J.J., Briere, F. & Trinchieri, G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol.171, 6466–6477 (2003). ArticleCAS Google Scholar
Yu, Y. et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J. Immunol.166, 1590–1600 (2001). ArticleCAS Google Scholar
Ferlazzo, G. et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol.33, 306–313 (2003). ArticleCAS Google Scholar
Pien, G.C., Satoskar, A.R., Takeda, K., Akira, S. & Biron, C.A. Selective IL-18 requirements for induction of compartmental IFN-γ responses during viral infection. J. Immunol.165, 4787–4791 (2000). ArticleCAS Google Scholar
Gerosa, F. et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol.174, 727–734 (2005). ArticleCAS Google Scholar
Jinushi, M. et al. Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol.170, 1249–1256 (2003). ArticleCAS Google Scholar
Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity12, 721–727 (2000). ArticleCAS Google Scholar
Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N. & Raulet, D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol.1, 119–126 (2000). ArticleCAS Google Scholar
Diefenbach, A., Hsia, J.K., Hsiung, M.Y. & Raulet, D.H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol.33, 381–391 (2003). ArticleCAS Google Scholar
Carayannopoulos, L.N., Naidenko, O.V., Fremont, D.H. & Yokoyama, W.M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol.169, 4079–4083 (2002). ArticleCAS Google Scholar
Raulet, D. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol.3, 781–790 (2003). ArticleCAS Google Scholar
Scalzo, A.A., Fitzgerald, N.A., Simmons, A., La Vista, A.B. & Shellam, G.R. _Cmv_1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med.171, 1469–1483 (1990). ArticleCAS Google Scholar
Scalzo, A.A. et al. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics49, 238–241 (1999). ArticleCAS Google Scholar
van Dommelen, S.L.H., Tabarias, H.A., Smyth, M.J. & Degli-Esposti, M.A. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol.77, 1877–1884 (2003). ArticleCAS Google Scholar
Loh, J., Chu, D.T., O'Guin, A.K., Yokoyama, W.M. & Virgin, H.W.t. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol.79, 661–667 (2005). ArticleCAS Google Scholar
Tay, C.H. & Welsh, R.M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol.71, 267–275 (1997). CAS Google Scholar
Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA101, 3516–3521 (2004). ArticleCAS Google Scholar
Orange, J.S. & Biron, C.A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol.156, 1138–1142 (1996). CAS Google Scholar
Morelli, A.E. et al. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood98, 1512–1523 (2001). ArticleCAS Google Scholar
Kamath, A.T., Sheasby, C.E. & Tough, D.F. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-αβ and IFN-γ. J. Immunol.174, 767–776 (2005). ArticleCAS Google Scholar
Sun, J. et al. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J. Immunol.174, 742–751 (2005). ArticleCAS Google Scholar
Semino, C., Angelini, G., Poggi, A. & Rubartelli, A.N.K. iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood106, 609–616 (2005). ArticleCAS Google Scholar
Cerwenka, A., Baron, J.L. & Lanier, L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA98, 11521–11526 (2001). ArticleCAS Google Scholar
Diefenbach, A., Jensen, E.R., Jamieson, A.M. & Raulet, D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature413, 165–171 (2001). ArticleCAS Google Scholar
Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med.197, 1245–1253 (2003). ArticleCAS Google Scholar
Lodoen, M.B. et al. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60–NKG2D interactions. J. Exp. Med.200, 1075–1081 (2004). ArticleCAS Google Scholar
Hasan, M. et al. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J. Virol.79, 2920–2930 (2005). ArticleCAS Google Scholar
Krmpotic, A. et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med.201, 211–220 (2005). ArticleCAS Google Scholar
Ogasawara, K. et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity18, 41–51 (2003). ArticleCAS Google Scholar
Krmpotic, A. et al. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol.3, 529–535 (2002). ArticleCAS Google Scholar
Compton, T. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol.77, 4588–4596 (2003). ArticleCAS Google Scholar
Milone, M.C. & Fitzgerald-Bocarsly, P. The mannose receptor mediates induction of IFN-α in peripheral blood dendritic cells by enveloped RNA and DNA viruses. J. Immunol.161, 2391–2399 (1998). CAS Google Scholar
Allan, J.E. & Shellam, G.R. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch. Virol.81, 139–150 (1984). ArticleCAS Google Scholar